Click here to register for the first time.
Email
Password
Like olympic gymnasts, every year the best companies get more agile. As the world’s largest drug maker, Pfizer is braced for change. It has cut staff and recently, for the first time, revenues from outside the US overtook revenues from inside. Dr. Jo Read More...
Like olympic gymnasts, every year the best companies get more agile. As the world’s largest drug maker, Pfizer is braced for change. It has cut staff and recently, for the first time, revenues from outside the US overtook revenues from inside. Dr. Jorge Puente, Pfizer’s regional president of Worldwide Pharmaceuticals, is one of the leaders driving a new competitive strategy.
In this interview, you will find out:
Why Jorge’s background is key to his way of thinking about Pfizer
How a two-fold strategy cracked Asia, and what that two-fold strategy is
Why ‘free’ works, even outside of the Internet
Is 'free' ever a good competitive strategy?
I applaud Dr. Puente's initiative in connecting first hand with the needs of the consumer and moving big pharma to do the right thing in support of free medications for the recently unemployed. This is definitely a step in the right direction moving across the globe from the US to Japan, China, Korea, Europe and beyond.
Well, I surely take my hat off to Pfizer for their 'bridging the gap' program.
In order to post a comment you need to be registered and logged in.
In the early part of the 20th century, the developed world experienced a major transition from a ba... read more
Over the past three decades, executive compensation has risen dramatically, far surpassing the wage... read more